Press Releases

Expanded Intelligent Surgical Unit™ (ISU™) capabilities include 3D measurement, digital tagging, image enhancement, and enhanced camera control, for our European customers RESEARCH TRIANGLE PARK, N.C. , Jan. 23, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc.

RESEARCH TRIANGLE PARK, N.C. , Jan. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2022

RESEARCH TRIANGLE PARK, N.C. , Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the management team

First hospital to install a second Senhance Surgical System RESEARCH TRIANGLE PARK, N.C. , Jan. 03, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of

Continued expansion of the Senhance Program in the region RESEARCH TRIANGLE PARK, N.C. , Dec. 29, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of

10th hospital in Germany to initiate a Senhance System RESEARCH TRIANGLE PARK, N.C. , Dec. 19, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of

Oncology focused hospital to initiate Senhance System program RESEARCH TRIANGLE PARK, N.C. , Dec. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of

RESEARCH TRIANGLE PARK, N.C. , Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab , Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech

RESEARCH TRIANGLE PARK, N.C. , Nov. 10, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and

First Hospital to Initiate a Senhance System Dedicated to Pediatric Procedures 9th Hospital in Germany to Utilize Senhance RESEARCH TRIANGLE PARK, N.C. , Nov. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between